Wolfgang Miesbach on Transforming Care for Women and Girls with Bleeding Disorders: Key Guidelines 2021–2024
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Advancing Care for Women and Girls with Bleeding Disorders
The clinical landscape has transformed significantly through evidence-based guidelines (2021-2024), finally addressing historical gaps in care for this mainly unrecognized population:
2021 ISTH Nomenclature Revolution
Eliminated outdated ‘carrier’ terminology
Established 5 evidence-based categories from severe to asymptomatic women and girls with bleeding disorders
Improved diagnostic accuracy and research uniformity
2021 ASH/ISTH/NHF/WFH VWD Guidelines
Prioritized hormonal therapy and tranexamic acid over desmopressin for heavy menstrual bleeding
Set clear diagnostic thresholds: <0.30 IU/mL (regardless of bleeding) and <0.50 IU/mL (with bleeding)
2021 European Principles of Care
EAHAD and EHC established 10 comprehensive care principles
Promoted systematic screening across European centers
2024 NBDF MASAC Guidelines
Document 286: Most comprehensive update yet
Mandated iron deficiency screening even with normal hemoglobin
Addressed historical underdiagnosis gaps
Persistent Challenges:
Despite progress, women and girls with bleeding disorders remain systematically excluded from clinical trials, creating dangerous knowledge gaps that impact:
Diagnostic delays
Higher anemia & transfusion rates
Unnecessary hysterectomies
25% report severe reproductive decision impact
The path forward requires collaborative research and gender-specific treatment studies to truly close these healthcare disparities.”
Stay informed with Hemostasis Today.
-
Nov 15, 2026, 10:17Ify Osunkwo: How the Sickle Cell Community Can Influence FDA Drug Development Priorities
-
Nov 15, 2026, 10:11Ahmed Abdelsalam: Why Matching ABO and RhD Groups Does Not Guarantee Crossmatch Compatibility
-
Nov 15, 2026, 10:06Asma Khalil: New British Society for Haematology Guidance on Paediatric and Neonatal Transfusion
-
Nov 15, 2026, 09:41Girishkumar Modi: Navigating the 2026 Jehovah’s Witness Transfusion Policy Shift in Clinical Practice
-
Nov 15, 2026, 04:31Aakriti Gupta: Anticoagulation for Leaflet Thickening After TAVR
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis
-
Nov 14, 2026, 23:46Habib Bennaceur: Moving Towards Fewer Limitations for People Living With Haemophilia